This result demonstrated the presence of a therapeutic window of opportunity to avoid irreversible BD, even though increasing evidence indicates that anti-TNF therapy could achieve higher mucosal healing and deep remission rates [21–23]. The gene discussed is TNF; the disease is Behcet disease.